Art

J-GLOBAL ID：201802275873692529   Reference number：18A1196031

Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer

T2N0声門癌に対する従来の分割放射線療法と低用量毎日のシスプラチン+毎週ドセタキセルとの同時化学放射線療法【JST・京大機械翻訳】

Author (10)： Saitoh Jun-ichi (Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Shirai Katsuyuki (Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Imaeda Masumi (Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Musha Atsushi (Gunma University Heavy Ion Medical Center, Maebashi, Japan) ,  Abe Takanori (Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Shino Masato (Department of Otolaryngology-Head & Neck Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Takayasu Yukihiro (Department of Otolaryngology-Head & Neck Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Takahashi Katsumasa (Department of Otolaryngology-Head & Neck Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Chikamatsu Kazuaki (Department of Otolaryngology-Head & Neck Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Nakano Takashi (Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan)
Material： Radiation Oncology (Web)
Volume： 12  Issue： 1  Page： 39  Publication year： 2017 
JST Material Number： U7343A  ISSN： 1748-717X  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Background To assess the effic...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1196031&from=J-GLOBAL&jstjournalNo=U7343A") }}

Thesaurus term： follow-up study ,  larynx ,  drug therapy ,  Safety ,  toxicity ,  Necrosis ,  patient ,  *Radiotherapy ,  survival ratio ,  *Concurrent chemoradiotherapy ,  *low dosage ,  *platinum complex ,  *antitumor drug ,  *ammine complex ,  *chloro complex ,  5 years survival rate ,  air duct (respiration)
Semi thesaurus term： *cisplatin ,  局所制御 ,  5年全生存率 , 【Automatic Indexing@JST】

Author keywords (4)： Laryngeal cancer ,  Radiation therapy ,  Chemotherapy ,  Voice preservation

JST classification (2)： Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Treatment for tumors in general  (GE03031L)

Reference (23)：

• Laryngoscope; The effect of overall treatment time of radiation therapy on local control of T1-stage squamous cell carcinoma of the glottis; K Hayakawa, N Mitsuhashi, T Akimoto, K Maebayashi, H Ishikawa, K Hayakawa; 106; 1996; 1545-7; 10.1097/00005537-199612000-00020; CR1;
• Radiother Oncol; Radiation therapy for T1, 2 glottic carcinoma: impact of overall treatment time on local control; Y Nishimura, Y Nagata, K Okajima, M Mitsumori, M Hiraoka, S Masunaga; 40; 1996; 225-32; 10.1016/0167-8140(96)01796-3; CR2;
• Int J Radiat Oncol Biol Phys; Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis; CH Terhaard, K Snippe, LA Ravasz, I Tweel, GJ Hordijk; 21; 1991; 1179-86; 10.1016/0360-3016(91)90274-8; CR3;
• Head Neck; The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?; AS Jones, B Fish, JE Fenton, DJ Husband; 26; 2004; 127-35; 10.1002/hed.10361; CR4;
• Int J Radiat Oncol Biol Phys; T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy; BS Chera, RJ Amdur, CG Morris, JM Kirwan, WM Mendenhall; 78; 2; 2010; 461-6; 10.1016/j.ijrobp.2009.08.066; CR5;

Terms in the title (6)： 声門癌 ,  放射線療法 ,  低用量 ,  シスプラチン ,  ドセタキセル ,  同時化学放射線療法